129 related articles for article (PubMed ID: 17044053)
1. Family-based case-control study of MAOA and MAOB polymorphisms in Parkinson disease.
Kang SJ; Scott WK; Li YJ; Hauser MA; van der Walt JM; Fujiwara K; Mayhew GM; West SG; Vance JM; Martin ER
Mov Disord; 2006 Dec; 21(12):2175-80. PubMed ID: 17044053
[TBL] [Abstract][Full Text] [Related]
2. Detection and analysis of four polymorphic markers at the human monoamine oxidase (MAO) gene in Japanese controls and patients with Parkinson's disease.
Nakatome M; Tun Z; Shimada S; Honda K
Biochem Biophys Res Commun; 1998 Jun; 247(2):452-6. PubMed ID: 9642149
[TBL] [Abstract][Full Text] [Related]
3. Gene-gene interaction between FGF20 and MAOB in Parkinson disease.
Gao X; Scott WK; Wang G; Mayhew G; Li YJ; Vance JM; Martin ER
Ann Hum Genet; 2008 Mar; 72(Pt 2):157-62. PubMed ID: 18205889
[TBL] [Abstract][Full Text] [Related]
4. Hereditary variations in monoamine oxidase as a risk factor for Parkinson's disease.
Hotamisligil GS; Girmen AS; Fink JS; Tivol E; Shalish C; Trofatter J; Baenziger J; Diamond S; Markham C; Sullivan J
Mov Disord; 1994 May; 9(3):305-10. PubMed ID: 7913737
[TBL] [Abstract][Full Text] [Related]
5. Association of variations in monoamine oxidases A and B with Parkinson's disease subgroups.
Parsian A; Racette B; Zhang ZH; Rundle M; Perlmutter JS
Genomics; 2004 Mar; 83(3):454-60. PubMed ID: 14962671
[TBL] [Abstract][Full Text] [Related]
6. Investigation of the functional effect of monoamine oxidase polymorphisms in human brain.
Balciuniene J; Emilsson L; Oreland L; Pettersson U; Jazin E
Hum Genet; 2002 Jan; 110(1):1-7. PubMed ID: 11810289
[TBL] [Abstract][Full Text] [Related]
7. Case-control study of dopamine transporter-1, monoamine oxidase-B, and catechol-O-methyl transferase polymorphisms in Parkinson's disease.
Goudreau JL; Maraganore DM; Farrer MJ; Lesnick TG; Singleton AB; Bower JH; Hardy JA; Rocca WA
Mov Disord; 2002 Nov; 17(6):1305-11. PubMed ID: 12465073
[TBL] [Abstract][Full Text] [Related]
8. Family- and population-based association studies of monoamine oxidase A and autism spectrum disorders in Korean.
Yoo HJ; Lee SK; Park M; Cho IH; Hyun SH; Lee JC; Yang SY; Kim SA
Neurosci Res; 2009 Mar; 63(3):172-6. PubMed ID: 19100789
[TBL] [Abstract][Full Text] [Related]
9. Association study of monoamine oxidase and catechol-O-methyltransferase genes with smoking behavior.
Tochigi M; Suzuki K; Kato C; Otowa T; Hibino H; Umekage T; Kato N; Sasaki T
Pharmacogenet Genomics; 2007 Oct; 17(10):867-72. PubMed ID: 17885625
[TBL] [Abstract][Full Text] [Related]
10. Monoamine oxidase genes polymorphisms and mood disorder.
Muramatsu T; Matsushita S; Kanba S; Higuchi S; Manki H; Suzuki E; Asai M
Am J Med Genet; 1997 Sep; 74(5):494-6. PubMed ID: 9342198
[TBL] [Abstract][Full Text] [Related]
11. Identification of a risk haplotype of the alpha-synuclein gene in Japanese with sporadic Parkinson's disease.
Kobayashi H; Ujike H; Hasegawa J; Yamamoto M; Kanzaki A; Sora I
Mov Disord; 2006 Dec; 21(12):2157-64. PubMed ID: 17078049
[TBL] [Abstract][Full Text] [Related]
12. Association analysis of the functional MAOA gene promoter and MAOB gene intron 13 polymorphisms in tension type headache patients.
Edgnülü TG; Özge A; Erdal N; Kuru O; Erdal ME
Adv Clin Exp Med; 2014; 23(6):901-6. PubMed ID: 25618115
[TBL] [Abstract][Full Text] [Related]
13. Association of a monoamine oxidase B allele with Parkinson's disease.
Kurth JH; Kurth MC; Poduslo SE; Schwankhaus JD
Ann Neurol; 1993 Apr; 33(4):368-72. PubMed ID: 8489207
[TBL] [Abstract][Full Text] [Related]
14. Catechol-O-methyltransferase and monoamine oxidase B genes and susceptibility to sporadic Parkinson's disease in a Polish population.
Białecka M; Droździk M; Honczarenko K; Gawrońska-Szklarz B; Stankiewicz J; Dabrowska E; Kubisiak M; Kłodowska-Duda G; Opala G
Eur Neurol; 2005; 53(2):68-73. PubMed ID: 15753616
[TBL] [Abstract][Full Text] [Related]
15. Family-based case-control study of cigarette smoking and Parkinson disease.
Scott WK; Zhang F; Stajich JM; Scott BL; Stacy MA; Vance JM
Neurology; 2005 Feb; 64(3):442-7. PubMed ID: 15699372
[TBL] [Abstract][Full Text] [Related]
16. Smoking, caffeine, and nonsteroidal anti-inflammatory drugs in families with Parkinson disease.
Hancock DB; Martin ER; Stajich JM; Jewett R; Stacy MA; Scott BL; Vance JM; Scott WK
Arch Neurol; 2007 Apr; 64(4):576-80. PubMed ID: 17420321
[TBL] [Abstract][Full Text] [Related]
17. Exploration of 19 serotoninergic candidate genes in adults and children with attention-deficit/hyperactivity disorder identifies association for 5HT2A, DDC and MAOB.
Ribasés M; Ramos-Quiroga JA; Hervás A; Bosch R; Bielsa A; Gastaminza X; Artigas J; Rodriguez-Ben S; Estivill X; Casas M; Cormand B; Bayés M
Mol Psychiatry; 2009 Jan; 14(1):71-85. PubMed ID: 17938636
[TBL] [Abstract][Full Text] [Related]
18. alpha-Synuclein and Parkinson disease susceptibility.
Winkler S; Hagenah J; Lincoln S; Heckman M; Haugarvoll K; Lohmann-Hedrich K; Kostic V; Farrer M; Klein C
Neurology; 2007 Oct; 69(18):1745-50. PubMed ID: 17872362
[TBL] [Abstract][Full Text] [Related]
19. The relationship between monoamine oxidase B (MAOB) A644G polymorphism and Parkinson disease risk: a meta-analysis.
Liu Y; Wang Z; Zhang B
Ann Saudi Med; 2014; 34(1):12-7. PubMed ID: 24658549
[TBL] [Abstract][Full Text] [Related]
20. Variations in the monoamine oxidase B (MAOB) gene are associated with Parkinson's disease.
Mellick GD; Buchanan DD; McCann SJ; James KM; Johnson AG; Davis DR; Liyou N; Chan D; Le Couteur DG
Mov Disord; 1999 Mar; 14(2):219-24. PubMed ID: 10091612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
